Samsung Bioepis Receives EU Bevacizumab Approval

Company Gets Fifth Biosimilar Approval By European Commision

 
• By Akriti Seth
Oncology
Samsung Bioepis gets a second oncology biosimilar approval for Europe • Source: Shutterstock

More from Biosimilars

More from Products